Search

The fasciocutaneous flap transplanted into the oral cavity often acquires a gross appearance resembling that of intraoral mucosa. The purpose of this study was to analyze the histologic and morphological changes of the fasciocutaneous free flap in oropharyngeal reconstruction and attempt to determine the related causes. A study was done from January 2006 to February 2010. Study subjects included 67 of 239 patients who had undergone reconstructive surgery after oropharyngeal tumor resection. Histologic evaluation of biopsy specimens was also performed in 20 patients. The correlation of the morphological changes with various factors was analyzed. The histologic examination revealed that numerous histologic changes occurred although the overall structure of the skin was maintained. Analysis of the associated factors showed that the primary defect site was highly correlated with this morphological change in the intraoral flaps.Analysis of the associated factors showed that the primary defect site was highly correlated with this morphological change in the intraoral flaps. Histologic analysis reveals that fasciocutaneous free flaps maintain their feature as cutaneous skin yet undergo changes because of the characteristic oral cavity environment, which resulted in an intermediate-stage morphology.

We assessed the association among ultrasonographically detected non-alcoholic fatty liver disease (US-NAFLD), metabolic syndrome (MetS), and insulin resistance (IR) in non-obese, non-diabetic middle-aged adults, to find out whether US-NAFLD is independently associated with IR in this population.A total of 5,878 non-obese (body mass index, ≥ 18.5 and25), non-diabetic individuals were analyzed. IR was estimated with the homeostasis model assessment index (HOMA2-IR) and defined when HOMA2-IR ≥ 1.5. MetS was defined by the Adult Treatment Panel III (ATP III) criteria.MetS was present in 381 (6.5%) participants, IR was present in 801 (13.6%) participants, and US-NAFLD was present in 1,611 (27.4%) participants. The increase in the prevalence of US-NAFLD closely followed the increase in the number of metabolic components diagnosed according to the ATP III criteria (15.2%, 28.5%, 48.0%, 65.7%, 71.4%, and 100% for 0, 1, 2, 3, 4, and 5 metabolic components, respectively, P0.001). US-NAFLD showed a significantly higher odds ratio (OR) for IR, regardless of the number of metabolic components (OR (95% confidence interval) of 3.48 (2.45-4.94), 3.63 (2.74-4.82), 3.19 (2.29-4.44), and 2.43 (1.43-3.81) for 0, 1, 2, and ≥ 3 metabolic components, respectively, P0.001 for all values). MetS showed a low sensitivity (0.22) for the identification of individuals with IR, and either US-NAFLD alone (0.60) or US-NAFLD with MetS (0.66) improved sensitivity with acceptable trade-off in specificity.US-NAFLD was an independent predictor for IR, irrespective of the number of metabolic components of MetS in the non-obese, non-diabetic middle-aged Asian adults. US-NAFLD could identify individuals with IR that cannot be identified by MetS in this population.